News

EMZ supports Biogroup LCD’s external growth strategy

EMZ supports Biogroup LCD’s external growth strategy

EMZ has arranged a bond financing at the occasion of the acquisition of LCD laboratories by Biogroup

Biogroup LCD is a group of routine medical biology held by its funder Stéphane Eimer, biologist. The group has successfully led a growth strategy in Eastern France over the past 20 years.

In November 2015, Biogroup acquired LCD. This acquisition allows the group to diversify its geographical footprint in entering in the Ile de France region (Paris and surroundings), and strengthening its leadership position by becoming the third largest player in the French market with 147 laboratories under operation.

Being 100% owned by Stéphane Eimer and other biologists, Biogroup LCD appears as the largest independent player in the French medical biology.

Links:
Press release
Website